PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)

NCT00221702 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

898

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Neoplasm Metastasis

Interventions

DRUG: PegIntron
DRUG: intron A

Sponsor

University Hospital, Bordeaux

Collaborators

[object Object]